Consumer Safety Watch

Intrauterine Devices (IUD) with progestogen have been marketed as a safe alternative to birth control pills and other options such as the patch or injections, but Consumer Safety Watch says manufacturers have failed to warn women and their doctors of the link to pseudotumor cerebri.

Onglyza belongs to a class of diabetes medications called DPP-4 inhibitors, FDA clinical trial data shows there may be a risk of death for some patients.